Gelonghui, April 8, 丨 Hongyuan Pharmaceutical (301246.SZ) announced that on April 3, 2024, the company repurchased shares through centralized bidding transactions for the first time through a special stock repurchase securities account. The number of shares repurchased was 110,000 shares, accounting for 0.0275% of the company's current total share capital. The highest transaction price for the repurchase was 17.92 yuan/share, the minimum transaction price was 17.79 yuan/share, and the total transaction amount was 19.09.85 million yuan (excluding transaction fees).
宏源药业(301246.SZ):首次回购11万股 涉资196.099万元
Hongyuan Pharmaceutical (301246.SZ): Initial repurchase of 110,000 shares involving 1.960.99 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.